Cope Now Unveils Innovative Telehealth Platform Dedicated to CBD Medical Care

Denver — Kazmira Therapeutics has rolled out Cope Now, a new telehealth service that gives patients access to clinician-supervised CBD treatment. The platform went live on May 28 in Colorado and plans to expand to other states soon.

The launch marks another step for Kazmira Therapeutics, a company that has built a full chain of operations in the cannabinoid space. It already runs Kazmira Pharmacy, which it describes as the only 503A compounding pharmacy in the United States dedicated to pure CBD formulas that contain no THC.

Pulak Sharma, co-founder and co-CEO of Kazmira Therapeutics, said the platform was created to meet a clear need. Many people want to use CBD for health reasons but struggle to find consistent, high-quality options with proper medical guidance. Cope Now aims to change that by combining virtual doctor visits with pharmacy-grade products.

Patients start with a telehealth consultation led by licensed clinicians. These visits assess whether prescription-strength CBD makes sense for their situation. Arora Health provides the full clinical oversight, handling patient evaluations, dosing recommendations, and follow-up care. This setup is meant to create a safer and more professional experience than typical over-the-counter CBD products.

The service works closely with Kazmira Pharmacy. Because it operates as a 503A compounding facility, the pharmacy can prepare customized CBD doses based on a clinician’s prescription. This approach allows for precise, consistent formulations that meet stricter pharmaceutical standards.

Kazmira positions itself as the first fully vertically integrated cannabinoid company in the country. It handles everything from active ingredient production to pharmacy compounding and now telehealth services. Company leaders believe this control helps maintain quality and meet regulatory requirements at every step.

The timing of the launch reflects broader trends in healthcare. Telehealth use has grown steadily since the pandemic, and interest in non-psychoactive CBD options continues to rise. At the same time, regulators are paying closer attention to how hemp-derived products are sold and used. Platforms like Cope Now try to operate in the middle ground by offering medical supervision rather than general wellness marketing.

Dr. Sean Arora of Arora Health has stressed the value of strong clinical guardrails. His team focuses on building real patient-provider relationships and making sure people understand how CBD might fit into their care. This emphasis on oversight sets Cope Now apart from retail CBD brands that operate without medical involvement.

For now, the service is available only in Colorado. Eligible patients can visit the Cope Now website to book a virtual appointment. If approved, they receive a prescription that Kazmira Pharmacy fills and ships directly. The company expects to open the platform in more states as it clears regulatory and operational hurdles.

Industry watchers see potential in this model. The U.S. telehealth market is projected to keep growing through the next decade as patients seek convenient care. In the CBD sector, demand remains strong for products that target issues such as anxiety, chronic pain, and sleep problems. However, many consumers still face confusion over product quality and effectiveness in the unregulated retail market.

Cope Now enters this space with a prescription-based system. Supporters say it brings more legitimacy to CBD use by adding medical review and standardized dosing. At the same time, the company must navigate complex federal and state rules around cannabinoids and telehealth services.

Kazmira Therapeutics has not released specific targets for patient numbers or revenue from the new platform. The company says it will monitor early results in Colorado before pushing into additional markets.

The development comes as the broader cannabis and hemp industries continue to mature. More companies are exploring ways to combine technology, pharmacy services, and clinical care to meet rising consumer demand while satisfying regulators.

Patients in Colorado interested in the service can find more details at copenow.com. As the platform expands, it will likely draw attention from both healthcare providers and investors looking at the intersection of telehealth and cannabinoid medicine.